E.136 - Investing in Psychedelics ft. Tim Schlidt Co-Founder of Palo Santo

Tune in to E.136 featuring Tim Schlidt, Co-Founder and partner at Palo Santo as we discuss investing in psychedelics. Palo Santo's diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions in today’s world. We discuss the  rising mental health conditions facing people around the world and how psychedelics are well positioned to address this problem. Tim also explains how many of the companies in Palo Santo's portfolio are taking an authentic and innovative approach to healthcare. We have an in-depth conversation about big Pharma's role in this evolution and the idea of synthetically deriving these compounds. Tim explains what the implications of this will be for both patients as well as the indigenous communities who utilize these compounds for ceremonial purposes. The show wraps up discussing some of the creative work these companies are producing in the field and where the future of psychedelics might be in the next 5-10 years. If you are looking to learn more about the future of investing in psychedelics give this episode a listen!